Inflation Reduction Act & Medicare Part D Public Comments

RE: CMS Proposed Exclusion of 340B Drug Units from Medicare Inflation Rebate Calculations [CMS-1832-P; RIN 0938-AV50] (September 5, 2025)
RE: Sign-On Letter in Support of Medicare Drug Price Negotiation Program Carve-Out Exemption for Medications Indicated for the Treatment of HIV/AIDS (August 20, 2025)
RE: Written testimony to the Centers for Medicare & Medicaid Services expressing concerns about the 2028 Medicare Drug Price Negotiation Program Draft Guidance, and asking for an HIV carve-out (June 25, 2025)